ICATIBANT
Generic: ICATIBANT
Fresenius Kabi USAManufacturer
SUBCUTANEOUSRoute
ICATIBANT ACETATEActive Substance
2020-06-18Original Approval
ICATIBANT is FDA application ANDA208317, sponsored by FRESENIUS KABI USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
HEREDITARY ANGIOEDEMA
981 reports
2
DRUG INEFFECTIVE
277 reports
3
WEIGHT INCREASED
276 reports
4
WEIGHT DECREASED
262 reports
5
PRODUCT DOSE OMISSION ISSUE
259 reports
6
PRODUCT USE ISSUE
245 reports
7
MALAISE
207 reports
8
HEADACHE
203 reports
9
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION
191 reports
10
STRESS
175 reports